Sequencing antigen‐targeting antibodies and cellular therapies in adults with relapsed/refractory B‐cell acute lymphoblastic leukemia

The recent approvals of four CD19‐or CD22‐targeted therapies for B‐cell acute lymphoblastic leukemia (B‐ALL) have transformed the treatment of relapsed/refractory (r/r) disease. Adults with r/r B‐ALL are usually eligible for all options, but there are no studies directly comparing these agents, and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of hematology 2023-04, Vol.98 (4), p.666-680
Hauptverfasser:	Aldoss, Ibrahim, Shah, Bijal D., Park, Jae H., Muffly, Lori, Logan, Aaron C., Brown, Patrick, Stock, Wendy, Jabbour, Elias J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Acute lymphoblastic leukemia Adult Antibodies, Bispecific - therapeutic use Antigens, CD19 CD19 antigen CD22 antigen Cell therapy Hematology Humans Immunotherapy, Adoptive Lymphatic leukemia Lymphoma, B-Cell Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!